RHT Resonance Health Limited
—Mkt Cap: —P/E: —1d ago
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, …
Industry Peers
Health Information Services$50.68BUSDP/E 52.1
$12.83BUSD
$12.34BUSDP/E 55.2
$8.47BUSDP/E 34.6
$7.65BUSDP/E 33.5
$5.61BUSDP/E 37.1
$5.41BUSDP/E 39.2
$4.43BUSD
$2.89BUSDP/E 107.7
$1.91BUSD
$1.64BUSDP/E 43.8
$1.47BUSD
$1.20BUSDP/E 70.1
$1.14BUSDP/E 77.8
$1.08BUSD
$1.03BUSDP/E 46.9
$685.26MUSDP/E 64.9
$620.58MUSD
$594.53MUSD
$580.72MUSDP/E 31.4
Key Statistics
Company
Market Cap—
Enterprise Value25.99M USD
Revenue (TTM)10.89M USD
Gross Profit10.51M USD
Net Income (TTM)1.05M USD
Revenue/Share0.03 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryHealth Information Services
ISINAU000000RHT2
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG2.55
EV/EBITDA16.36
EV/Revenue2.39
P/S2.45
P/B3.52
EPS (TTM)0.00
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin96.58%
Oper. Margin7.72%
EBITDA Margin14.59%
Profit Margin9.61%
ROE14.76%
ROA6.28%
Growth
Revenue Growth32.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.99M USD
CapEx (TTM)260.76K USD
FCF Margin12.40%
FCF Yield—
Net Debt-717.82K USD
Net Debt/EBITDA-0.45
Balance Sheet
Debt/Equity0.34
Current Ratio1.13
Quick Ratio1.11
Book Value/Sh0.02 AUD
Cash/Share0.01 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateOct 15, 2003
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.477.12M
Float287.79M
Insiders40.63%
Institutions0.00%
Technical
SMA 500.0644 AUD
SMA 2000.0494 AUD
Beta1.01
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)653.27K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—